Management of a pregnant patient with Graves' disease complicated by propylthiouracil induced agranulocytosis

Korean Journal of Internal Medicine

Volumn 20, Issue 4, 2005, Pages 335-338

  Cho, Yoon Young ^a   Ho, Sang Shon ^a   Hyun, Dae Yoon ^a,b  

^a The Catholic University of Korea   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

Agranulocytosis; Graves' disease; Pregnancy; Propylthiouracil

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEPHALOSPORIN; LEVOTHYROXINE; LUGOL; PROPRANOLOL DERIVATIVE; PROPYLTHIOURACIL; THIONAMIDE; THYROXINE; ANTITHYROID AGENT;

ADULT; AGRANULOCYTOSIS; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; FETUS ECHOGRAPHY; GESTATION PERIOD; GRANULOCYTOSIS; GRAVES DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; LABOR INDUCTION; LABORATORY TEST; PHYSICAL EXAMINATION; PREGNANT WOMAN; RELAPSE; THORAX RADIOGRAPHY; THYROIDECTOMY; THYROTOXICOSIS; TREATMENT OUTCOME; VITAL SIGN; CHEMICALLY INDUCED DISORDER; PREGNANCY; PREGNANCY COMPLICATION; RECURRENT DISEASE;

ADULT; AGRANULOCYTOSIS; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PROPYLTHIOURACIL; RECURRENCE; THYROIDECTOMY;

EID: 33645824949     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2005.20.4.335     Document Type: Article

References (14)

1. Roti E, Minelli R, Salvi M. Clinical review 80: management of hyperthyroidism and hypothyroidism in the pregnant woman. J Clin Endocrinol Metab 81:1679-1682, 1996
2. Toth EL, Mant MJ, Shivji S, Ginsberg J. Propylthiouracil-induced agranulocytosis: an unusual presentation and a possible mechanism. Am J Med 85:725-727, 1988
3. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160:63-70, 1989
4. Momotani N, Ito K. Treatment of pregnant patients with Basedow's disease. Exp Clin Endocrinol 97:268-274, 1991
5. Romaldini JH, Werner MC, Bromberg N, Werner RS. Adverse effects related to antithyroid drugs and their dose regimen. Exp Clin Endocrinol 97:261-264, 1991
6. Kato Y, Kuwabara T, Itoh T, Hiura M, Hatori A, Shigematsu A, Hara T. A possible relationship between abortions and placental embolism in pregnant rabbits given human granulocyte colony-stimulating factor. J Toxicol Sci 26:39-50, 2001
7. Ghaneim A, Atkins P. Management of thyrotoxicosis in pregnancy. Int J Clin Pract 52:36-38, 1998
8. Winsa B, Rastad J, Larsson E, Mandahl A, Westermark K, Johansson H, Juhlin C, Karlsson A, Akerstrom G. Total thyroidectomy in therapy-resistant Graves' disease. Surgery 116:1068-1074, 1994
9. Catz B, Perzik SL. Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease. Am J Surg 118:434-439, 1969
10. Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A. Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery 120:1020-1024, 1996
11. Pruyn SC, Phelan JP, Buchanan GC. Long-term propranolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet Gynecol 135:485-489, 1979
12. Mestman JH. Hyperthyroidism in pregnancy. Endocrinol Metab Clin North Am 27:127-149, 1998
13. Dangers of iodides in pregnancy. Lancet 1:1273-1274, 1970
14. Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. J Clin Endocrinol Metab 75:738-744, 1992